Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Yang Li, Ying Sun, Yang Zhou, Xinyang Li, Huan Zhang & Guojun Zhang. (2021) Discovery of orally active chalcones as histone lysine specific demethylase 1 inhibitors for the treatment of leukaemia. Journal of Enzyme Inhibition and Medicinal Chemistry 36:1, pages 207-217.
Read now
Read now
Øystein Bruserud, Elise Aasebø, Maria Hernandez-Valladares, Galina Tsykunova & Håkon Reikvam. (2017) Therapeutic targeting of leukemic stem cells in acute myeloid leukemia – the biological background for possible strategies. Expert Opinion on Drug Discovery 12:10, pages 1053-1065.
Read now
Read now
Mirjam Hau, Fides Zenk, A. Ganesan, Nicola Iovino & Manfred Jung. (2017) Cellular analysis of the action of epigenetic drugs and probes. Epigenetics 12:5, pages 308-322.
Read now
Read now
Articles from other publishers (28)
Hui‐Min Liu, Ying Zhou, He‐Xiang Chen, Jiang‐Wan Wu, Shi‐Kun Ji, Liang Shen, Shao‐Peng Wang, Hong‐Min Liu, Ying Liu, Xing‐Jie Dai & Yi‐Chao Zheng. (2023) LSD1 in drug discovery: From biological function to clinical application. Medicinal Research Reviews.
Crossref
Crossref
Zhao Deng & Des R. Richardson. (2023) The Myc Family and the Metastasis Suppressor NDRG1: Targeting Key Molecular Interactions with Innovative Therapeutics. Pharmacological Reviews 75:5, pages 1007-1035.
Crossref
Crossref
Jiyong Wu, Jing Nie, Yepeng Luan & Yanjiao Ding. (2023) Hybrid Histone Deacetylase Inhibitor: An Effective Strategy for
Cancer Therapy. Current Medicinal Chemistry 30:20, pages 2267-2311.
Crossref
Crossref
Lihong Shan, Zhaoxiang Li, Huabin Chen, Meng Ge, Yingying Sun, Ying Sun, Yaru Li, Hongyu Li, Ling Fu & Hongmin Liu. (2023) 6-Heterocyclic carboxylic ester derivatives of gliotoxin lead to LSD1 inhibitors in gastric cancer cells. Bioorganic Chemistry 131, pages 106150.
Crossref
Crossref
Muthu K. Shanmugam, Chakrabhavi Dhananjaya Mohan, Kanchugarakoppal S. Rangappa, Alan Prem Kumar & Gautam Sethi. 2023. Transcription and Translation in Health and Disease. Transcription and Translation in Health and Disease
325
357
.
Li-Min Zhao, Shuai Wang, Christophe Pannecouque, Erik De Clercq, Hu-Ri Piao & Fen-Er Chen. (2022) Discovery of novel biphenyl-substituted pyridone derivatives as potent non-nucleoside reverse transcriptase inhibitors with promising oral bioavailability. European Journal of Medicinal Chemistry 240, pages 114581.
Crossref
Crossref
Xinran Wang, Cai Zhang, Xiangyu Zhang, Jiming Wang, Liyu Zhao, Dongmei Zhao & Maosheng Cheng. (2022) Design, synthesis and biological evaluation of 2-aminopyrimidine-based LSD1 inhibitors. Bioorganic Chemistry 121, pages 105699.
Crossref
Crossref
Xingrui He, Hang Zhang, Yingqian Zhang, Yang Ye, Shuo Wang, Renren Bai, Tian Xie & Xiang-Yang Ye. (2022) Drug discovery of histone lysine demethylases (KDMs) inhibitors (progress from 2018 to present). European Journal of Medicinal Chemistry 231, pages 114143.
Crossref
Crossref
Khuloud Bajbouj, Abeer Al-Ali, Rakhee K. Ramakrishnan, Maha Saber-Ayad & Qutayba Hamid. (2021) Histone Modification in NSCLC: Molecular Mechanisms and Therapeutic Targets. International Journal of Molecular Sciences 22:21, pages 11701.
Crossref
Crossref
Jiangkun Yan, Yanting Gu, Yixiang Sun, Ziheng Zhang, Xiangyu Zhang, Xinran Wang, Tianxiao Wu, Dongmei Zhao & Maosheng Cheng. (2021) Design, synthesis, and biological evaluation of 5‐aminotetrahydroquinoline‐based LSD1 inhibitors acting on Asp375. Archiv der Pharmazie 354:8, pages 2100102.
Crossref
Crossref
Lingjuan Zeng, Chunyan Chen & Chanjiao Yao. (2021) Histone Deacetylation Regulated by KDM1A to Suppress DACT1 in Proliferation and Migration of Cervical Cancer. Analytical Cellular Pathology 2021, pages 1-16.
Crossref
Crossref
Dong-Jun Fu, Jun Li & Bin Yu. (2021) Annual review of LSD1/KDM1A inhibitors in 2020. European Journal of Medicinal Chemistry 214, pages 113254.
Crossref
Crossref
Olga Salamero, Pau Montesinos, Christophe Willekens, José Antonio Pérez-Simón, Arnaud Pigneux, Christian Récher, Rakesh Popat, Cecilia Carpio, César Molinero, Cristina Mascaró, Joaquim Vila, M. Isabel Arévalo, Tamara Maes, Carlos Buesa, Francesc Bosch & Tim C. P. Somervaille. (2020) First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia. Journal of Clinical Oncology 38:36, pages 4260-4273.
Crossref
Crossref
Satoshi Nozaki, Taku Naiki, Aya Naiki‐Ito, Shoichiro Iwatsuki, Tomoki Takeda, Toshiki Etani, Takashi Nagai, Keitaro Iida, Hiroyuki Kato, Takayoshi Suzuki, Satoru Takahashi, Yukihiro Umemoto & Takahiro Yasui. (2020) Selective lysine‐specific demethylase 1 inhibitor, NCL1, could cause testicular toxicity via the regulation of apoptosis. Andrology 8:6, pages 1895-1906.
Crossref
Crossref
Yuan Fang, Guochao Liao & Bin Yu. (2019) LSD1/KDM1A inhibitors in clinical trials: advances and prospects. Journal of Hematology & Oncology 12:1.
Crossref
Crossref
Anthony K. N. Chan & Chun-Wei Chen. (2019) Rewiring the Epigenetic Networks in MLL-Rearranged Leukemias: Epigenetic Dysregulation and Pharmacological Interventions. Frontiers in Cell and Developmental Biology 7.
Crossref
Crossref
Sina Jostes, Daniel Nettersheim & Hubert Schorle. (2019) Epigenetic drugs and their molecular targets in testicular germ cell tumours. Nature Reviews Urology 16:4, pages 245-259.
Crossref
Crossref
Xiaowen Wang, Mingbo Su, You Li, Tongchao Liu, Yujie Wang, Yabing Chen, Le Tang, Yu-Peng He, Xiaoguang Ding, Fang Yu, Jingkang Shen, Jia Li, Yubo Zhou, Yue-Lei Chen & Bing Xiong. (2019) Tranylcypromine and 6-trifluoroethyl thienopyrimidine hybrid as LSD1 inhibitor. Bioorganic & Medicinal Chemistry Letters 29:6, pages 844-847.
Crossref
Crossref
Bin Yu & Hong-Min Liu. 2019. Pharmacoepigenetics. Pharmacoepigenetics
523
530
.
Yingchao Duan, Wenping Qin, Fengzhi Suo, Xiaoyu Zhai, Yuanyuan Guan, Xiaojuan Wang, Yichao Zheng & Hongmin Liu. (2018) Design, synthesis and in vitro evaluation of stilbene derivatives as novel LSD1 inhibitors for AML therapy. Bioorganic & Medicinal Chemistry 26:23-24, pages 6000-6014.
Crossref
Crossref
Daniela Morales-Lara, Clelia De-la-Peña & Eric Murillo-Rodríguez. (2017) Dad’s Snoring May Have Left Molecular Scars in Your DNA: the Emerging Role of Epigenetics in Sleep Disorders. Molecular Neurobiology 55:4, pages 2713-2724.
Crossref
Crossref
Yuchen Chen, Xinran Liu, Yangkai Li, Chuntao Quan, Ling Zheng & Kun Huang. (2018) Lung Cancer Therapy Targeting Histone Methylation: Opportunities and Challenges. Computational and Structural Biotechnology Journal 16, pages 211-223.
Crossref
Crossref
Guilherme Fernandes, Gabriel Silva, Aline Pavan, Diego Chiba, Chung Chin & Jean Dos Santos. (2017) Epigenetic Regulatory Mechanisms Induced by Resveratrol. Nutrients 9:11, pages 1201.
Crossref
Crossref
Xiaoli Fu, Peng Zhang & Bin Yu. (2017) Advances toward LSD1 inhibitors for cancer therapy. Future Medicinal Chemistry 9:11, pages 1227-1242.
Crossref
Crossref
Jiayue Xi, Siyuan Xu, Liming Wu, Tianfang Ma, Rongfeng Liu, Yu-Chih Liu, Dawei Deng, Yueqing Gu, Jinpei Zhou, Fei Lan & Xiaoming Zha. (2017) Design, synthesis and biological activity of 3-oxoamino-benzenesulfonamides as selective and reversible LSD1 inhibitors. Bioorganic Chemistry 72, pages 182-189.
Crossref
Crossref
Ana Cañete, Elena Cano, Ramón Muñoz-Chápuli & Rita Carmona. (2017) Role of Vitamin A/Retinoic Acid in Regulation of Embryonic and Adult Hematopoiesis. Nutrients 9:2, pages 159.
Crossref
Crossref
Taira Maekawa. 2017. Chemotherapy for Leukemia. Chemotherapy for Leukemia
343
361
.
lihong shan, Zhaoxiang Li, Huabin Chen, Meng Ge, Yingying Sun, Ying Sun, Yaru Li, Hongyu Li, Ling Fu & Hong-Min Liu. (2022) 6-Heterocyclic Carboxylic Ester Derivatives of Gliotoxin Lead to LSD1 Inhibitors in Gastric Cancer Cells. SSRN Electronic Journal.
Crossref
Crossref